Skip to content

Public FDA record

Z-2783-2011: Bard PowerLine 6 Fr. Dual-Lumen Polyurethane Catheter with SureCuff Ingrowth Cuff, REF 0700610, Sterile,

Recall record Z-2783-2011 for Bard Access Systems. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2783-2011
Company in FDA record
Bard Access Systems
FDA classification date
Jul 11, 2011
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Kit label indicates the wrong dimension for an enclosed introducer.

Source facts

Action
Bard Access Systems, Inc. notified customers by letter dated June 16, 2011. The letter notified customers of the mislabeling issue and offered a replacement product if desired. For additional information contact Bard Access Systems at 1-800-443-3393.
Initiated
2011-06-20
Root cause
Labeling design
Terminated
2012-03-01
Distribution
Worldwide distribution - USA (nationwide) including the states of: HI, KY, TX, VT and the country of Canada.
Recall number
Z-2783-2011
Recall status
Terminated
CDRH record ID
101247
FDA classified
2011-07-11
Recall event number
59115

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗